- Home
- BANX vs MYO Comparison
BANX vs MYO Comparison
Compare BANX & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANX
- MYO
- Stock Information
- Founded
- BANX 2013
- MYO 2004
- Country
- BANX United States
- MYO United States
- Employees
- BANX N/A
- MYO N/A
- Industry
- BANX Trusts Except Educational Religious and Charitable
- MYO Industrial Specialties
- Sector
- BANX Finance
- MYO Health Care
- Exchange
- BANX Nasdaq
- MYO Nasdaq
- Market Cap
- BANX 149.0M
- MYO 153.0M
- IPO Year
- BANX N/A
- MYO 2017
- Fundamental
- Price
- BANX $20.24
- MYO $4.37
- Analyst Decision
- BANX
- MYO Strong Buy
- Analyst Count
- BANX 0
- MYO 4
- Target Price
- BANX N/A
- MYO $9.75
- AVG Volume (30 Days)
- BANX 25.8K
- MYO 301.7K
- Earning Date
- BANX 06-13-2025
- MYO 05-07-2025
- Dividend Yield
- BANX 10.45%
- MYO N/A
- EPS Growth
- BANX N/A
- MYO N/A
- EPS
- BANX 2.35
- MYO N/A
- Revenue
- BANX $29,467,794.00
- MYO $32,551,198.00
- Revenue This Year
- BANX N/A
- MYO $32.15
- Revenue Next Year
- BANX N/A
- MYO $17.59
- P/E Ratio
- BANX $8.61
- MYO N/A
- Revenue Growth
- BANX 2.73
- MYO 69.17
- 52 Week Low
- BANX $17.91
- MYO $2.51
- 52 Week High
- BANX $21.67
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- BANX 51.50
- MYO 40.76
- Support Level
- BANX $18.37
- MYO $4.21
- Resistance Level
- BANX $19.24
- MYO $4.62
- Average True Range (ATR)
- BANX 0.67
- MYO 0.34
- MACD
- BANX 0.06
- MYO -0.01
- Stochastic Oscillator
- BANX 71.66
- MYO 41.34
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds, and others.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).